Safety and immunogenicity of a replication deficient simian adenoviral vectored chikungunya vaccine: A phase I, first-in-human, dose escalation trial
Үндсэн зохиолчид: | , , , , , , , , , , , , , , , , , |
---|---|
Формат: | Conference item |
Хэл сонгох: | English |
Хэвлэсэн: |
American Society of Tropical Medicine and Hygiene
2019
|